Safety Study of LiRIS in Interstitial Cystitis (IC) Patients
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is primarily to evaluate the safety and tolerability of two dose
levels of an investigational drug-delivery system (LiRIS) in patients who have moderate to
severe symptoms of interstitial cystitis.